Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Columbia, SC
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Rapid City, SD
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Madison, WI
Treatment for Completers of the Study B7A-MC-MBCM
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
Phase 3, Multicenter,Parallel,Randomized Dbl-masked,Placebo-controlled Study of the Effects of 32 mg/dy Ruboxistaurin Vision Loss in Patients With Type 1 or Type 2 Diabetes Mellitus and an Early Treatment Diabetic Retinopathy Study Level Between 47A and 53E.
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
Phase 3, Multicenter,Parallel,Randomized Dbl-masked,Placebo-controlled Study of the Effects of 32 mg/dy Ruboxistaurin Vision Loss in Patients With Type 1 or Type 2 Diabetes Mellitus and an Early Treatment Diabetic Retinopathy Study Level Between 47A and 53E.
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Valley Endocrine, Fresno
mi
from
Fresno, CA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Valley Endocrine, Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
National Research Institute
mi
from
Los Angeles, CA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Desert Medical Group Inc.
mi
from
Palm Springs, CA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Desert Medical Group Inc.
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Encompass Clinical Research
mi
from
Spring Valley, CA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Encompass Clinical Research
mi
from
Spring Valley, CA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Meridien Research
mi
from
Bradenton, FL
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
M & O Clinical Research, LLC
mi
from
Fort Lauderdale, FL
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
M & O Clinical Research, LLC
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Suncoast Research Group, LLC
mi
from
Miami, FL
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Suncoast Research Group, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Compass Research
mi
from
Oviedo, FL
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Compass Research
mi
from
Oviedo, FL
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Clinical Research of Central Florida
mi
from
Winter Haven, FL
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Clinical Research of Central Florida
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
East West Medical Institute
mi
from
Honolulu, HI
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
East West Medical Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Univ of Hawaii
mi
from
Honolulu, HI
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Univ of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Rocky Mountain Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Rocky Mountain Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Iderc, P.L.C.
mi
from
Des Moines, IA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Iderc, P.L.C.
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Cotton O'Neil Diabetes and Endocrinology Center
mi
from
Topeka, KA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Cotton O'Neil Diabetes and Endocrinology Center
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Mercy Medical Research Institute
mi
from
Springfield, MO
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Mercy Medical Research Institute
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
St John's Mercy Medical Center
mi
from
St Louis, MO
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
St John's Mercy Medical Center
mi
from
St Louis, MO
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Mercy Health Research
mi
from
Washington, MO
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Mercy Health Research
mi
from
Washington, MO
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Southern New Hampshire Diabetes and Endocrinology
mi
from
Nashua, NH
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Southern New Hampshire Diabetes and Endocrinology
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
High Point Clinical Trials Center
mi
from
High Point, NC
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
High Point Clinical Trials Center
mi
from
High Point, NC
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Lillestol Research LLC
mi
from
Fargo, ND
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Lillestol Research LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
The Corvallis Clinic, PC
mi
from
Corvallis, OR
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
The Corvallis Clinic, PC
mi
from
Corvallis, OR
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Blair Medical Associates Inc.
mi
from
Altoona, PA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Blair Medical Associates Inc.
mi
from
Altoona, PA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Texas Diabetes & Endocrinology, PA
mi
from
Austin, TX
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Texas Diabetes & Endocrinology, PA
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
San Gabriel Clinical Research
mi
from
Georgetown, TX
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
San Gabriel Clinical Research
mi
from
Georgetown, TX
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Oakwell Clinical Research
mi
from
San Antonio, TX
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Oakwell Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Southwest Health Associates, P.A.
mi
from
Sugar Land, TX
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Southwest Health Associates, P.A.
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
Wade Family Medicine
mi
from
Bountiful, UT
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
Wade Family Medicine
mi
from
Bountiful, UT
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
John Muir Physician Network Clinical Research Center
mi
from
Concord, CA
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
John Muir Physician Network Clinical Research Center
mi
from
Concord, CA
Click here to add this to my saved trials
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/23/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Ampelokipoi,
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/23/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Ampelokipoi,
Click here to add this to my saved trials
Diabetes, Lipoproteins and Accelerated Vascular Disease
Measures of Postprandial Lipoproteins Are Not Associated With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/23/2015
Columbia University
mi
from
New York, NY
Diabetes, Lipoproteins and Accelerated Vascular Disease
Measures of Postprandial Lipoproteins Are Not Associated With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/23/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Adult Subjects With Uncontrolled Type 2 Diabetes
A Multi-center, Double Blind, Randomized, Placebo-controlled, Parallel Group Phase IIa Study of MLR-1023 in Adult Subjects With Uncontrolled Type 2 Diabetes
Status: Enrolling
Updated:  12/28/2015
Melior Pharmaceuticals I & Bukwang Pharm. Co., Ltd.
mi
from
USA and South Korea, PA
Adult Subjects With Uncontrolled Type 2 Diabetes
A Multi-center, Double Blind, Randomized, Placebo-controlled, Parallel Group Phase IIa Study of MLR-1023 in Adult Subjects With Uncontrolled Type 2 Diabetes
Status: Enrolling
Updated: 12/28/2015
Melior Pharmaceuticals I & Bukwang Pharm. Co., Ltd.
mi
from
USA and South Korea, PA
Click here to add this to my saved trials
Continuous Glucose Monitoring in Youth With Type 2 Diabetes
Continuous Glucose Monitoring in Youth With Type 2 Diabetes
Status: Enrolling
Updated:  1/4/2016
Yale Pediatric Diabetes Research Program
mi
from
New Haven, CT
Continuous Glucose Monitoring in Youth With Type 2 Diabetes
Continuous Glucose Monitoring in Youth With Type 2 Diabetes
Status: Enrolling
Updated: 1/4/2016
Yale Pediatric Diabetes Research Program
mi
from
New Haven, CT
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
Phoenix VA Health Care System
mi
from
Phoenix, AZ
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
Phoenix VA Health Care System
mi
from
Phoenix, AZ
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
University of Arizona
mi
from
Tuscon, AZ
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
University of Arizona
mi
from
Tuscon, AZ
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
Center for Clinical Research Castro Valley
mi
from
Castro Valley, CA
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
Center for Clinical Research Castro Valley
mi
from
Castro Valley, CA
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
Limb Preservation Platform
mi
from
Fresno, CA
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
VA Long Beach Health System
mi
from
Long Beach, CA
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
VA Long Beach Health System
mi
from
Long Beach, CA
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
Miami VA Healthcare System
mi
from
Miami, FL
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
Miami VA Healthcare System
mi
from
Miami, FL
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
MetroWest Medical Center
mi
from
Framingham, MA
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
MetroWest Medical Center
mi
from
Framingham, MA
Click here to add this to my saved trials
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated:  1/4/2016
Greenville Health System
mi
from
Greenville, SC
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/4/2016
Greenville Health System
mi
from
Greenville, SC
Click here to add this to my saved trials